Avacta Group PLC (LSE:AVCT) - Share price - Overview

Stock Report

Avacta Group PLC AVCT

Last Price
GBX63.00

Day Change
0.00|0.00%

As of 27/03/2017
15:27:43 BST | GBX
Minimum 15 Minutes Delay.

Last Close63.00p
Day Range62.00 - 63.38
Mkt Cap43.08Mil
52-Wk Range61.50 - 116.00
Yield %0.00
ISINGB00BYYW9G87
Volume17,553
P/E-9.32
P/S19.71
P/CF-10.08

Share Price

Total Returns 27/03/2017

 Chg (%)  
More ...
Avacta Group PLC-5.26 
FTSE 100 TR GBP1.52
 
Financials
201420152016
More ...
Income Statement
Turnover1.621.812.17
Operating Profit-2.05-5.57-5.66
Net Profit-1.47-4.89-4.65
Reported EPS-4.00-20.10-6.86
Balance Sheet
Current Assets13.369.5022.34
Non Current Assets17.6911.9115.22
Total Assets31.0521.4037.55
Current Liabilities1.741.801.67
Total Liabilities2.212.271.70
Total Equity28.8419.1335.86
Cash Flow
Operating Cash Flow-1.28-0.34-4.90
Net Change in Cash10.90-4.152.19
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-7.62-8.95--7.04---
2018-8.50-9.90--6.36---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
11/01/2017PurchaseDr. Michael Albin72.004,3403,125.00
16/12/2016Transfer inTony Gardiner0.0022,9730.00
16/12/2016Exercise of OptionTony Gardiner74.0022,97317,000.00
16/12/2016Transfer inMr. Craig Slater0.0031,3520.00

Company Profile

Avacta Group PLC is engaged in research, development, production and delivery of instrumentation and services for the biopharmaceutical drug development and clinical diagnostics markets using biophysical technology.

Sector

Medical Devices

Market Position

1141 of 1853 Companies

Index

FTSE AIM All Share

Outlook

(01/12/2016) ch - "...we are extremely optimistic about 2017"

Next Event 03/04/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)-6.5914.4416.15
Div Yld (E)0.003.684.12
PEG (E)0.000.301.01
ROCE-22.56180.55121.20
Op Mrgn-258.52-11.48-8.23
EPS Grwth0.0085.6736.58
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Trevor Nicholls
Chief ExecutiveProf Alastair Smith
Chief Financial Officer & Company SecretTony Gardiner
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.